Jun 14, 2023 / 09:40PM GMT
Corinne Jenkins - Goldman Sachs Group, Inc., Research Division - VP
Great. Welcome, everyone, and welcome, especially to the team from BioXcel Therapeutics. Today, we have Vimal Mehta, CEO; Rob Risinger, CMO; and then we've got Matt Wiley, Chief Commercial Officer. So thanks to all of you for joining, and thanks to everyone who's joining us here and on the webcast.
Questions and Answers:
Corinne Jenkins - Goldman Sachs Group, Inc., Research Division - VPMaybe just to start, could you level set with a brief overview of the company with perhaps a particular focus on what you see as key value drivers over the next 12 to 24 months?
Vimal D. Mehta - BioXcel Therapeutics, Inc. - Founder, CEO, President, & Director
Great. Thank you, Corinne, for hosting us, and good afternoon, everyone. BioXcel Therapeutics is a biopharmaceutical company developing innovative medicines in neuroscience and immuno-oncology using artificial intelligence-based platform.
In terms of where we are, we've been now, like a public